MedicaidCoverageLow impact
Newsletter Vol. 33, No.17
New Jersey Medicaid·NJ · Family Medicine, Internal Medicine, General Practice +2 more·Provider Notice
We identified it
Jun 20, 2026
Summary
This policy provides additional guidance for the Naloxone365 Initiative, which appears to be related to naloxone (opioid overdose reversal medication) coverage or distribution programs. Without the full policy content, specific billing changes cannot be determined from the summary alone.
Action Required
Review the full policy document at https://www.njmmis.com/documentDownload.aspx?document=33-17.pdf to understand specific requirements for naloxone-related billing or coverage changes under the Naloxone365 Initiative.